OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Salvatore Battaglia, Antonio D’Alessio, Giulia Francesca Manfredi, Bernardo Stefanini, Naoshi Nishida, Peter R. Galle, Kornelius Schulze, Henning Wege, Roberta Ciccia, Wei‐Fan Hsu, Caterina Vivaldi, Brooke Wietharn, Po Ting Lin, Angelo Pirozzi, Tiziana Pressiani, Andrea Dalbeni, Leonardo Antonio Natola, A. Auriemma, Cristina Rigamonti, Michela Emma Burlone, Alessandro Parisi, Yi‐Hsiang Huang, Pei‐Chang Lee, Celina Ang, Thomas U. Marron, Matthias Pinter, Jaekyung Cheon, Hong Jae Chon, Samuel Phen, Amit Singal, Anuhya Gampa, Anjana Pillai, Robert Thimme, Arndt Vogel, Noha Soror, Susanna V. Ulahannan, Rohini Sharma, David Sacerdoti, Mario Pirisi, Lorenza Rimassa, Chun‐Yen Lin, Anwaar Saeed, Natascha Röhlen, Gianluca Masi, Martin Schoenlein, Johann von Felden, Masatoshi Kudo, Alessio Cortellini, Calogero Cammà, David J. Pinato